Early Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis
Authors:
Open Access
- 1 January 2016
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 55 (22) , 3351-3356
Abstract
The prognosis for myelodysplastic syndrome with bone marrow fibrosis (MDS-F) is worse than the prognosis of MDS without fibrosis. Hematopoietic stem cell transplantation (HSCT) is the only curative therapy; however, the indications and the procedures involved in HSCT remain unclear. We herein describe a 69-year-old Japanese man with MDS-F who received haploidentical HSCT and post-transplantation cyclophosphamide. Although the first HSCT resulted in secondary graft failure, the second HSCT using PTCy led to successful engraftment after early improvement in fibrosis. Since the incidence of graft failure is high in myelofibrosis patients, a secondary HSCT using PTCy may be successful if employed.Keywords
This publication has 20 references indexed in Scilit:
- Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative ConditioningTransplantation and Cellular Therapy, 2013
- Salvage haploidentical transplantation for graft failure using reduced-intensity conditioningBone Marrow Transplantation, 2011
- Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosisHaematologica, 2010
- Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosisBlood, 2010
- Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential ThrombocythemiaTransplantation and Cellular Therapy, 2007
- Regression of Myelofibrosis and Osteosclerosis following Hematopoietic Cell Transplantation Assessed by Magnetic Resonance Imaging and Histologic GradingTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- European consensus on grading bone marrow fibrosis and assessment of cellularity.2005
- Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaBlood, 2002
- Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entityBritish Journal of Haematology, 1991